New insights into the underlying mechanisms of Type 2 diabetes and novel potential therapeutic targets for the disease were revealed in a recent study by a team of Texas A&M AgriLife Research ...
Wanbao Yang, Ph.D., (left) graduate student and the study’s first author, and Shaodong Guo, Ph.D., who served as its principal investigator. (Texas A&M AgriLife photo by Tyler Morales) The study, ...
Add Yahoo as a preferred source to see more of our stories on Google. Alpha cells in the pancreas produce GLP-1, reshaping our understanding of blood sugar control and diabetes care. (CREDIT: ...
New findings raise the possibility of promising therapeutic strategies for the management of hypoglycemia in type 1 diabetes patients. Study: Loss of electrical β-cell to δ-cell coupling underlies ...
A new study led by Ananda Basu, M.D., used novel non-radioactive, stable glucagon tracers for the first time to characterize glucagon metabolism in humans with and without Type 1 diabetes, providing ...
In patients with type 1 diabetes (T1D), sodium-glucose cotransporter 2 (SGLT2) inhibitors plus glucagon receptor antagonists (GRAs) may improve glycemic control, reduce insulin use, and mitigate ...
People with diabetes take insulin to lower high blood sugar. However, if glucose levels plunge too low—from taking too much insulin or not eating enough sugar—people can experience hypoglycemia, which ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results